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Background/Purpose: Despite provision of free-of-charge human immunodeficiency virus (HIV) care
and antiretroviral therapy in Taiwan, a substantial proportion of patients experience late HIV diagnosis.
We investigated the risk factors for late HIV diagnosis in Taiwan.
Methods: Structured interviews were conducted among newly diagnosed HIV-infected patients to collect
data on demographics, socio-behavioral variables and clinical profiles within 1 year preceding HIV diag-
nosis from August 2006 to July 2008. Multivariate analysis was performed to identify factors associated
with missed opportunities for HIV testing and late HIV diagnosis (< 200 CD4 cells/μL).
Results: Among 227 newly diagnosed HIV-infected patients, 107 (47%) had late HIV diagnosis. Patients
who had first positive tests for HIV at voluntary testing sites [odds ratio (OR): 0.22; 95% confidence inter-
val (CI): 0.10–0.50], regular sexual partners at HIV diagnosis (OR: 0.30; 95% CI: 0.14–0.68), and unpro-
tected sex in the preceding 3 months (OR: 0.16; 95% CI: 0.07–0.34) were less likely to have late HIV
diagnosis. Missed opportunities for HIV testing after seeking medical attention occurred in 47 patients
(20.7%) and were more common in patients with late HIV diagnosis than in those who received an earlier
diagnosis (23.0% vs. 15.8%, p = 0.03). Patients with late HIV diagnosis were more likely than their counter-
parts to have received a diagnosis of seborrheic dermatitis (7.4% vs. 0.8%, p = 0.02) and community-acquired
pneumonia (5% vs. 0%, p = 0.02), for which HIV testing was not offered by the health care providers.
Conclusion: Late HIV diagnosis is not uncommon in Taiwan. Regular risk assessment and provision 
of routine HIV testing in medical encounters and increase of accessibility to voluntary HIV testing could
facilitate earlier diagnosis of HIV infection.
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Early diagnosis of human immunodeficiency virus
(HIV) infection has a major clinical and public
health impact.1,2 It can facilitate timely initiation
of highly active antiretroviral therapy (HAART),
which delays disease progression and improves
survival. Early HIV testing and counseling might
also contribute to reduced HIV transmission be-
cause HIV-infected individuals reduce their risk
behaviors shortly after learning of their HIV
serostatus.3 Furthermore, patients with late HIV
diagnosis have significantly higher costs of medical
care than those with earlier diagnosis.4
However, a large number of HIV-infected pa-
tients receive their first diagnosis at an advanced
stage in the era of HAART.5–7 In western countries,
such as the United States, United Kingdom, Italy
and Canada, 24–45% of HIV-infected patients are
not aware of their HIV serostatus until they de-
velop acquired immunodeficiency syndrome.5–8
Despite endeavors to improve HIV care, the pro-
portion of patients with late HIV diagnosis among
all HIV-infected patients has remained stable in the
past decade.7 In western countries, late HIV diag-
nosis is more commonly seen among those who
perceive themselves at low risk for HIV transmis-
sion, are not actively offered HIV testing, and are
from marginalized groups.7 Increased risk for late
HIV diagnosis has been shown to be associated
with older age, male sex, heterosexual contact, un-
employment, non-white ethnicity, migrant status,
and living in low HIV prevalence areas, whereas
previous HIV testing and patient-initiated testing
reduces the chance of late HIV diagnosis.4,9–23
The prevalence and risk factors for late HIV
diagnosis are less well characterized in Asia. In
Hong Kong, Korea and Southern Thailand, the
prevalence of late HIV diagnosis ranges from 41%
to 55%, which is subject to selection bias because
of enrollment from voluntary reporting systems
or referral hospitals.24–26 Reported risk factors for
late HIV diagnosis in Asian studies are generally
unmodifiable, including older age, male sex,
Chinese ethnicity, unemployment, and not being
men who have sex with men (MSM).24,26 The
impact of behavioral factors and physician alert-
ness on late HIV diagnosis remains poorly studied,
and understanding these modifiable factors could
provide opportunities for public health interven-
tions to enhance timely HIV testing.
In this study, we investigated the role of socio-
behavioral factors and medical encounters in late
HIV diagnosis in Taiwan where free voluntary HIV
testing has been available since 1995, and HAART
has been provided free of charge to all HIV-infected
patients since April 1997.
Patients and Methods
Study population
From August 1, 2006 to July 31, 2008, this pro-
spective study was conducted among HIV-infected
individuals seeking HIV care at the National
Taiwan University Hospital; the largest referral
hospital for HIV in-patient and out-patient care
in Taiwan.27 The hospital also provides free-of-
charge anonymous voluntary counseling and test-
ing for HIV infection, and it was estimated that the
total annual number of persons seeking voluntary
counseling and testing services in this hospital
accounted for 25% of the total number reported
to Taiwan Centers for Disease Control during the
study period. HIV-infected patients aged ≥15 years
were consecutively enrolled if they had received
first positive HIV tests in the 3 months preceding
enrollment, and had CD4 cell counts determined
within 3 months of enrollment. Patients were 
excluded if they did not consent to the study or 
if they had difficulty in communication due to
medical or psychiatric illnesses. The study was
approved by the Institutional Review Board of the
hospital and all patients gave informed consent.
Interview and data collection
After HIV infection was confirmed, a structured
face-to-face confidential interview was performed
by the same investigator to collect detailed per-
sonal information. Three sets of variables were
collected from the interviews and medical records.
(1) Demographic variables that included age, sex,
and residence by administrative division. (2) Clini-
cal profiles that included initial CD4 cell count;
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hepatitis B virus (HBV) infection by presence of
HBV surface antigen; hepatitis C virus (HCV) in-
fection by presence of anti-HCV antibody; syphilis
by reactive non-treponemal tests (any positive
Venereal Disease Research Laboratory titer was
considered as reactive) with confirmation by posi-
tive treponemal tests (Treponema pallidum hemag-
glutination assay titer ≥ 1:160 was considered 
as positive); a history of sexually-transmitted dis-
eases (STDs), including gonorrhea, syphilis, non-
gonococcal urethritis, anogenital herpes simplex
virus infection, anogenital warts, chancroid and
genital ulcers of other causes; a history of illicit
drug use; and previous HIV testing and place of
first positive HIV test (acute and referral care set-
ting, voluntary testing sites, or sites that provide
compulsory HIV testing, including blood banks,
correctional facilities, military facilities and metha-
done clinics). (3) Social and behavioral variables
that included: living alone or not; perceived risk
for HIV transmission; mode of HIV transmission
(male homosexual or bisexual contact, hetero-
sexual contact, and injecting drug use); educa-
tion (< 12 years, or ≥ 12 years); any HIV-infected
friend; any regular sexual partner at the time of
HIV diagnosis; any unprotected sex in the past 
3 months; number of lifetime sexual partners;
employment status; and average monthly income
(cutoff at US$1300, the approximate monthly
Gross National Product per capita in Taiwan).
Enrolled patients were asked to recall the cir-
cumstances and offered diagnoses of each medical
visit within 1 year preceding the medical encounter
in which the first positive HIV test was ordered.
Patients were also asked to recall any inquiry of
risk factors for HIV infection, namely, sexual be-
haviors and injecting drug use, by the physician
if a diagnosis as listed above was recalled.
Definitions
Enrolled HIV-infected patients were defined as hav-
ing late HIV diagnosis if they had an initial CD4
cell count <200cells/μL, which is the most com-
monly employed definition of late HIV diagnosis.28
The recalled diagnoses were defined as “missed op-
portunities for HIV testing” if they fell in one of the
four subsets of the proposed clinical triggers for
HIV testing, but HIV testing was not provided:
(1) STD, namely herpes simplex virus infection,
gonorrhea, abnormal Papanicolaou smear, tricho-
moniasis, syphilis, chlamydia infection, pelvic
inflammatory disease, and condyloma acumi-
nata; (2) other infections, namely, tuberculosis,
recurrent vaginal candidiasis, community-acquired
pneumonia, and herpes zoster; (3) skin diseases,
namely, psoriasis and seborrheic dermatitis; (4)
systemic illness or conditions, namely, infectious
mononucleosis, weight loss, Bell’s palsy, gener-
alized lymphadenopathy or unexplained focal
adenopathy, and pregnancy.29 HBV infection, an
endemic infection in Taiwan, was not included as
a clinical trigger for HIV testing in this analysis.30
Statistical analysis
Univariate analysis was performed to assess the
associations between study variables and late HIV
diagnosis using χ2 analysis or Fisher’s exact test
for categorical variables and the Wilcoxon rank
sum test for non-categorical variables. All com-
parisons were two-tailed and a p value < 0.05 was
considered significant. Multivariate analysis was
performed by multinomial logistic regression that
incorporated the variables with p < 0.10 in the
univariate analysis. Data analysis was performed
using SPSS version 15.0 (SPSS, Chicago, IL, USA).
Results
During the 2-year study period, 287 newly diag-
nosed HIV-infected patients received medical care
at the National Taiwan University Hospital. A total
of 227 patients (79%) were included in the study.
Sixty patients were excluded: 40 did not consent
to participation in the study; and the other 20 had
difficulty in communication because of severe ill-
ness (11 with respiratory failure, 5 with central ner-
vous system infections, 3 with hepatic failure, and
1 with invasive oral cancer); of the latter group,
17 patients (85%) had a baseline CD4 cell count
< 200 cells/μL. Other than the finding that the
patients who were excluded were older (median
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age: 34 years vs. 31 years; p = 0.04), there were no
statistically significant differences between the
excluded and the enrolled patients in the propor-
tion of male sex (93% vs. 97%; p = 0.35); trans-
mission category (male homosexual or bisexual
contact, 72% vs. 81%; heterosexual, 22% vs. 15%;
and injecting drug use, 7% vs. 4%; p = 0.25);
baseline CD4 cell count (median: 213 cells/μL vs.
208 cells/μL; p = 0.59); and the proportion of 
patients with late HIV diagnosis (50% vs. 47%;
p = 0.69).
Table 1 summarizes the characteristics of the
227 patients that were included in the study. The
enrolled patients were primarily males and MSM,
who were aged 25–45 years. The majority of the
patients were highly educated, employed with a
monthly income higher than the average Gross
National Product per capita in Taiwan, and liv-
ing in urban areas. The median CD4 cell count
was 208 cells/μL and the median plasma viral
load was 5.02 log10 copies/mL.
Comparisons of socio-demographic, clinical
and behavioral characteristics between 107 pa-
tients with late HIV diagnosis (47%) and 120 
patients without late HIV diagnosis are summa-
rized in Table 1. The median CD4 cell count of
patients with and without late HIV diagnosis was
36 cells/μL and 346 cells/μL, respectively. In uni-
variate analysis, patients with late HIV diagnosis
were older (median age: 32 years vs. 29 years,
p = 0.006) and were more likely to have a lower
level of educational achievement and higher
monthly income than those without late diagno-
sis (Table 1). Both groups had a similar rate of
co-infection with HBV, HCV and syphilis, and a
previous history of STDs. Patients with late HIV
diagnosis were less likely than their counterparts
to have been tested for HIV before the first posi-
tive HIV results were available, to have under-
gone regular HIV testing, and to have a history of
illicit drug use, but were more likely to have first
positive tests at acute and referral care settings.
Of the illicit drugs used among all HIV-infected
patients, the most common ones were 4-methyl-
enedioxymethamphetamine (87%) and ketamine
(57%), which did not differ significantly between
patients with and without late HIV diagnosis;
heroin was used in eight patients. Patients with
late HIV diagnosis were less likely than their coun-
terparts to perceive themselves at high risk for HIV
infection, to be living alone, to have friends with
HIV infection, to have regular sexual partners at
HIV diagnosis, and to have had unprotected sex
in the past 3 months.
Multinomial logistic regression was performed
to identify factors that were independently asso-
ciated with late HIV diagnosis. The results are
shown in Table 2. In the analysis, having their
first positive tests at voluntary HIV testing sites
[odds ratio (OR): 0.22; 95% confidence interval
(CI): 0.10–0.50], regular sexual partnerships at
HIV diagnosis (OR: 0.30; 95% CI: 0.14–0.68), and
unprotected sex in the past 3 months (OR: 0.16;
95% CI: 0.07–0.34) were associated with less
likelihood to receive late HIV diagnosis.
Of 227 HIV-infected patients, a total of 47 
patients (20.7%) reported 49 episodes of missed
opportunities for HIV testing within the 1 year
preceding HIV diagnosis. Herpes zoster, sebor-
rheic dermatitis, community-acquired pneumo-
nia, and unexplained lymphadenopathy were the
most prevalent diagnoses that might have served
as clinical triggers for HIV testing but were missed
by the physician. The most common sites where
missed opportunities for HIV testing occurred
were dermatology clinics (29 episodes), internal
medicine clinics (7 episodes), and emergency
services (4 episodes). Of the 49 episodes of
missed opportunities for HIV testing, major HIV
risk factors were assessed in only three episodes
(6.1%).
Comparisons of missed opportunities for HIV
testing between patients with and without late
HIV diagnosis are summarized in Table 3. Missed
opportunities for HIV testing occurred more com-
monly in patients with late HIV diagnosis than
their counterparts (23.0% vs. 15.8%, p = 0.03).
Patients with late HIV diagnosis were more likely
than their counterparts to have received a diagnosis
of seborrheic dermatitis (7.4% vs. 0.8%, p = 0.02)
and community-acquired pneumonia (5% vs. 0%,
p = 0.02) without being offered HIV testing.
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Table 1. Socio-demographic, clinical and behavioral characteristics of human immunodeficiency virus-
infected patients with and without late diagnosisa
Variables
All
Late HIV diagnosis
pYes No(n = 227)
(n = 107) (n = 120)
Male 220 (96.9) 104 (97.2) 116 (96.7) 0.56
Age group (yr) 0.01
15–24 43 (18.9) 11 (10.3) 32 (26.7)
25–34 98 (43.2) 48 (44.9) 50 (41.7)
35–44 67 (29.5) 36 (33.6) 31 (25.8)
≥ 45 19 (8.3) 12 (11.2) 7 (5.8)
Mode of transmission 0.07
MSM 184 (81.1) 83 (77.6) 101 (84.2)
Heterosexual 35 (15.4) 22 (20.6) 13 (10.8)
IDU 8 (3.5) 2 (1.9) 6 (5.0)
Education 0.01
≤ 12 yr 73 (32.2) 43 (40.2) 30 (25.0)
> 12 yr 154 (67.8) 64 (59.8) 90 (75.0)
Employed 176 (77.5) 88 (82.2) 88 (73.3) 0.11
Average monthly income (US$) 0.03
< 1300 83 (36.6) 31 (29.0) 52 (43.3)
≥ 1300 144 (63.4) 76 (71.0) 68 (56.7)
Residence 0.57
Cities 203 (89.4) 97 (90.7) 106 (88.3)
Townships 24 (10.6) 10 (9.3) 14 (11.7)
Living alone 97 (42.7) 36 (33.6) 61 (50.8) 0.009
HBV co-infection 42 (18.5) 24 (22.4) 18 (15.0) 0.15
HCV co-infection 14 (6.2) 6 (5.6) 8 (6.7) 0.74
Syphilis co-infection 55 (24.2) 25 (23.4) 30 (25.0) 0.77
History of STD 82 (36.1) 40 (37.4) 42 (35.0) 0.71
History of illicit drug use 95 (41.9) 29 (27.1) 55 (69.5) < 0.001
Ever tested before the first positive HIV test 130 (57.3) 45 (42.1) 85 (70.8) < 0.001
Regular HIV testing 59 (26.0) 18 (16.8) 41 (34.2) 0.003
Place of HIV testing at first positive test < 0.001
Acute and referral care setting 119 (52.4) 81 (75.7) 38 (31.7)
Voluntary testing sites 94 (41.4) 21 (19.6) 73 (60.8)
HIV test requiring sites 14 (6.2) 5 (4.7) 9 (7.5)
Self-perceived HIV risk < 0.001
Low 104 (45.8) 65 (60.7) 39 (32.5)
High 123 (54.2) 42 (39.3) 81 (67.5)
Ever had HIV-infected friends 74 (32.6) 21 (19.6) 53 (44.2) < 0.001
Having regular sexual partners at HIV diagnosis 91 (40.1) 29 (27.1) 62 (51.7) < 0.001
Having unprotected sex in the past 3 months 109 (48.0) 26 (24.3) 83 (69.2) < 0.001
Number of lifetime sexual partners 0.72
≤ 10 59 (26.0) 27 (25.2) 32 (26.7)
11–50 85 (37.4) 38 (35.5) 47 (39.2)
> 50 83 (36.6) 42 (39.3) 41 (34.2)
aData are presented as n (%). HIV = human immunodeficiency virus; MSM = men who have sex with men; IDU = injecting drug user;
HBV = hepatitis B virus; HCV = hepatitis C virus; STD = sexually-transmitted disease.
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Table 2. Association of patient characteristics with late human immunodeficiency virus diagnosis in
multivariate analysis
Patient characteristics OR (95% CI) p
Age group (yr)
15–24 Referent
25–34 0.81 (0.18–3.69) 0.78
35–44 2.82 (0.52–15.2) 0.23
≥ 45 1.22 (0.27–5.48) 0.79
Mode of transmission
IDU Referent
MSM 0.79 (0.23–2.79) 0.72
Heterosexual 5.23 (0.50–54.7) 0.17
Education
≤ 12 yr Referent
> 12 yr 0.57 (0.25–1.32) 0.19
Average monthly income (US$)
≤ 1300 Referent
> 1300 2.01 (0.87–4.64) 0.10
History of illicit drug use
No Referent
Yes 1.08 (0.45–2.60) 0.87
Ever tested before the first positive HIV test
No Referent
Yes 0.79 (0.31–1.99) 0.61
Regular HIV testing
No Referent
Yes 1.16 (0.43–3.18) 0.77
Place of HIV testing at first positive test
HIV test requiring sites Referent
Acute and referral care setting 1.23 (0.27–5.62) 0.79
Voluntary testing sites 0.22 (0.10–0.50) < 0.001
Self-perceived HIV risk
Low Referent
High 0.49 (0.20–1.17) 0.11
Living alone
No Referent
Yes 1.18 (0.53–2.62) 0.69
Ever had HIV-infected friends
No Referent
Yes 0.70 (0.31–1.57) 0.38
Having regular sexual partners at HIV diagnosis
No Referent
Yes 0.30 (0.14–0.68) 0.004
Unprotected sex in the past 3 months
No Referent
Yes 0.16 (0.07–0.34) < 0.001
OR = odds ratio; CI = confidence interval; IDU = injecting drug user; MSM = men who have sex with men; HIV = human immunodeficiency
virus.
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Discussion
In this Taiwanese cohort that consisted predomi-
nantly of MSM, nearly half (47%) of newly diag-
nosed HIV-infected patients had late diagnosis,
which is in line with the reported prevalence
(41–55%) from other Asian studies,24–26 but is
lower than our previous studies in which late 
diagnosis was as prevalent as 83%, 69%, 64% 
in the pre-HAART period (June 1994 to March
1997), early post-HAART period (April 1997 to
June 2000), and late post-HAART period (July
2001 to June 2004), respectively.31 Although the
referral hospital setting in the present study al-
lowed for enrollment of patients with advanced
HIV infection, the decreasing trend of late HIV
diagnosis corresponded to enhanced utilization
of free voluntary HIV testing because of heavy
advocacy of HIV testing by the government and
peer groups. The average number of voluntary HIV
tests per month in this hospital increased from
104 to 214 throughout the study period (data not
shown). Despite wide availability of free anony-
mous HIV testing and free HAART in Taiwan 
for > 10 years, the high proportion of late HIV di-
agnosis indicates that free access to HIV testing and
care alone are not sufficient to facilitate early
HIV diagnosis among persons at risk.
In contrast to other studies, our study did not
demonstrate independent association between
late HIV diagnosis and conventional risk factors,
such as age, sex, mode of transmission, and em-
ployment status. Our study identified that fac-
tors associated with reduced likelihood for late
HIV diagnosis were having first positive tests at a
voluntary HIV testing site, having regular sexual
partnerships at HIV diagnosis, and having un-
protected sex in the past 3 months. It suggests
that, in Taiwan, accessibility to HIV testing and
behavioral characteristics play a much more im-
portant role than other largely unmodifiable
socio-demographic factors in making timely HIV
diagnosis, which could be translated into oppor-
tunities for public health interventions.
The contributory effect of voluntary HIV test-
ing to earlier HIV diagnosis, as shown in our
study, is in agreement with a previous study in
the United States that concluded there is a nega-
tive association between patient-initiated testing
and late HIV diagnosis.32 Patients who recognize
their own risk for HIV infection and actively seek
HIV testing are less likely to be diagnosed at a
Table 3. Prevalence of missed opportunities for human immunodeficiency virus testing among human
immunodeficiency virus-infected patients with and without late diagnosisa
Recalled diagnosis
All
Late HIV diagnosis
pYes No(n = 227)
(n = 107) (n = 120)
No. of patients 47 (20.7) 29 (27.1) 18 (15.0) 0.03
No. of episodes 49 (21.6) 30 (28.0) 19 (15.8) 0.03
Herpes zoster 13 (5.7) 6 (5.6) 7 (5.8) 0.95
Seborrehic dermatitis 9 (4.0) 8 (7.4) 1 (0.8) 0.02
Community-acquired pneumonia 6 (2.6) 6 (5.6) 0 (0) 0.02
Unexplained lymphadenopathy 6 (2.6) 2 (1.9) 4 (3.3) 0.79
Psoriasis 4 (1.7) 3 (2.8) 1 (0.8) 0.54
Syphilis 3 (1.3) 0 (0) 3 (2.5) 0.29
Tuberculosis 2 (0.9) 2 (1.9) 0 (0) 0.44
Condyloma acuminata 2 (0.9) 1 (0.9) 1 (0.8) 1.00
Mononucleosis 2 (0.9) 0 (0) 2 (1.6) 0.56
Weight loss 1 (0.4) 1 (0.9) 0 (0) 0.94
HSV infection 1 (0.4) 1 (0.9) 0 (0) 0.94
aData are presented as n (%). HIV = human immunodeficiency virus; HSV = herpes simplex virus.
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late stage. However, of all patients in our study,
> 40% were diagnosed at acute and referral care
settings, and nearly half did not perceive them-
selves to be at high risk for HIV transmission.
Although Taiwan has offered free-of-charge vol-
untary HIV testing nationwide since 1995, only 
a quarter of our patients undertook regular HIV
testing before diagnosis, which illustrates the 
urgent need for promotion of voluntary HIV test-
ing and improvement of its accessibility. Further
studies are warranted to examine the underlying
causes of low awareness of HIV infection and low
utilization of voluntary HIV testing in Taiwan.
Our study showed that regular sexual partner-
ship at HIV diagnosis was protective against late
HIV diagnosis. Homosexuality, bisexuality, infi-
delity and injecting drug use are all socially unac-
ceptable and morally disrespectful in Chinese
culture. As a result, HIV is frequently viewed as a
punishment for promiscuous sex and illegal drug
use in Taiwanese society.33 A positive HIV test
means disgrace and shame to one’s family and
career, therefore, the negative impact outweighs
the benefit and hence prohibits risk disclosure
and HIV testing. In addition, the presence of reg-
ular sexual partners might provide necessary sup-
port to counter expected negative consequences
of a positive HIV test and reinforce the patient’s
practice of HIV testing, which leads to earlier di-
agnosis. Nonetheless, nearly 60% of the patients
in our study had no regular sexual partnership 
at HIV diagnosis, which could reflect the dif-
ficulties in establishing sustained relationships
among Taiwanese populations at risk in such 
social contexts.
In this study, we also found that late HIV di-
agnosis was negatively associated with having
unprotected sex in the past 3 months preceding
HIV diagnosis. Lack of recent unprotected sex
might confer on patients a false sense of security
and overlook the long latency of HIV infection,
which can result in late diagnosis. Recent surveys
in Taiwan have shown the rates of consistent con-
dom use were low among college students and
MSM.34,35 It is therefore important to remind the
public that lack of recent unprotected sex does
not preclude someone from the risk of HIV 
acquisition.
In our study, 20.7% of patients had at least
one of the clinical triggers that have been sug-
gested in the literature for HIV testing within the
1 year preceding HIV diagnosis, and only 6.1%
of them were questioned by health care providers
about major HIV risk factors. Missed opportuni-
ties for HIV testing, such as seborrheic dermatitis
and community-acquired pneumonia, occurred
most commonly in dermatology clinics, internal
medicine clinics and emergency services, and
were associated with late HIV diagnosis. As HIV
seroprevalence in these clinical conditions are
unknown in Taiwan, it is unclear whether HIV
testing should be routinely provided to patients
with the listed clinical triggers. We recently have
demonstrated that < 30% of patients with tuber-
culosis and unknown HIV status were offered
HIV testing in a large medical center in Northern
Taiwan, and 5.6% of those tested were found to
be HIV-infected.36 However, the cost-effectiveness
of providing HIV testing to patients with tuber-
culosis needs to be investigated in Taiwan, where
tuberculosis is endemic but HIV incidence is low.
Further studies are warranted to examine the 
usefulness of these clinical triggers for early HIV
detection in Taiwan.
The only study that has reviewed medical en-
counters before HIV diagnosis in the United States
has concluded that increased recognition of clin-
ical indicators for HIV testing prompted earlier
HIV diagnosis in only 22% of patients, whereas
more effective risk evaluation by physicians in
asymptomatic patients was more likely to bring
about early HIV detection.32 Our results, consis-
tent with the previous study, showed that the
strategies to enhance earlier HIV diagnosis should
not rely solely on improving physicians’ alert-
ness to the clinical triggers listed for HIV testing.
Rather, physicians should be trained and encour-
aged to perform HIV risk assessment and testing
in any susceptible patient on a more regular and
less targeted basis.
However, most physicians feel inexperienced
and awkward bringing up taboo issues, such as
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sex and injecting drug use, with their patients.
The crowded public clinic or hospital setting that
is common in many Asian countries might limit
the time for physician and patient interactions.
To overcome these barriers and increase people’s
knowledge of their HIV status, more incentives
and education programs are required to motivate
physicians in active discussion with their patients
about HIV testing. It might be feasible to include
HIV testing as a routine part of healthcare prac-
tices for all adults and adolescents aged 13–64
years, as is suggested by the United States Centers
for Disease Control.37 More studies are warranted,
however, to examine whether routine HIV screen-
ing is cost-effective and practical in the health
care settings of Asian countries.
Our study was limited by its single-center set-
ting and MSM-predominant population. Caution
should be exercised when our results are general-
ized to other settings. In addition, the information
regarding patients’ previous medical encounters
is subject to recall bias.
In conclusion, late diagnosis is prevalent
among HIV-infected patients in Taiwan, and the
associated socio-behavioral factors that were iden-
tified in this study offered interventional oppor-
tunities. Strategies that focus solely on enhancing
clinical alertness of HIV-associated illnesses are
barely beneficial to earlier HIV diagnosis, whereas
regular HIV risk assessment and more routine
HIV testing should be encouraged in health care
practices.
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